The New York Times (1/5, Kolata ) said, “People taking the wildly popular drugs Ozempic, to treat diabetes, and Wegovy, to combat obesity, are slightly less likely to have suicidal thoughts than people who are not taking them, researchers reported on Friday.” The findings were published in Nature Medicine.
The AP (1/5, Aleccia ) reported NIH and Case Western Reserve University researchers found that “people taking semaglutide had a 49% to 73% lower risk of first-time or recurring suicidal thoughts than those taking another drug for those conditions during a six-month follow-up period.”
CNN (1/5, Tirrell ) reported, “The findings from the new study come days after the FDA said it was reviewing reports of suicidal ideation among people using semaglutide and similar medicines and evaluating the need for regulatory action.” Similarly, “the European Medicines Agency said in July that it was reviewing 150 reports of possible cases of self-injury and suicidal thoughts among people taking semaglutide and similar medicines.”
Related Links:
— “People taking Wegovy and Ozempic have lower risk of suicidal thoughts vs. older drugs, study finds,” Jones Aleccia, Associated Press, January 5, 2024